10:49 AM EDT, 08/08/2024 (MT Newswires) -- Monogram Technologies ( MGRM ) shares surged more than 16% in recent trading Thursday after it said the 510(k) premarket filing application for its mBos TKA knee-replacement system has passed its initial administrative review by the US Food and Drug Administration.

The application was submitted July 19, with a decision expected within 90 days of submission, although the company said that the deadline can be paused if the agency asks for additional information about the 3D-printed orthopedic implants and robotic surgery system.

Price: 2.59, Change: +0.36, Percent Change: +16.14